Insider Transactions in Q1 2025 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 24
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,304
-8.2%
|
$536,424
$31.0 P/Share
|
Jan 24
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,304
+7.58%
|
$86,520
$5.01 P/Share
|
Jan 23
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,098
-49.25%
|
$812,940
$30.08 P/Share
|
Jan 23
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,098
+33.0%
|
$54,196
$2.43 P/Share
|
Jan 22
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,269
-33.82%
|
$428,070
$30.08 P/Share
|
Jan 22
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,269
+25.27%
|
$28,538
$2.43 P/Share
|
Jan 21
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
300
-1.06%
|
$9,000
$30.0 P/Share
|
Jan 21
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+1.05%
|
$600
$2.43 P/Share
|
Jan 21
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
306
-0.16%
|
$8,568
$28.68 P/Share
|
Jan 21
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
306
+0.16%
|
$3,978
$13.9 P/Share
|
Jan 21
2025
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
67,687
-1.5%
|
$1,962,923
$29.19 P/Share
|
Jan 21
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
67,687
+8.04%
|
$0
$0.4 P/Share
|
Jan 21
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
54,153
-12.6%
|
$1,570,437
$29.34 P/Share
|
Jan 21
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+18.53%
|
$250,000
$5.01 P/Share
|
Jan 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-4.6%
|
$1,283,418
$27.12 P/Share
|
Jan 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,460
-17.43%
|
$984,420
$27.17 P/Share
|
Jan 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,668
+34.34%
|
$67,336
$2.43 P/Share
|
Jan 13
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-3.03%
|
$277,944
$24.51 P/Share
|
Jan 13
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+4.73%
|
$32,185
$5.01 P/Share
|
Jan 10
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,259
-3.61%
|
$174,216
$24.07 P/Share
|
Jan 10
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,259
+3.49%
|
$43,554
$6.82 P/Share
|
Jan 06
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
268,932
-34.74%
|
$7,261,164
$27.86 P/Share
|
Jan 06
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
254,023
+25.91%
|
$762,069
$3.72 P/Share
|
Jan 02
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-2.91%
|
$277,944
$24.68 P/Share
|
Jan 02
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+4.56%
|
$32,185
$5.01 P/Share
|
Jan 02
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,055
-1.05%
|
$49,320
$24.62 P/Share
|
Jan 02
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,055
+1.04%
|
$22,605
$11.53 P/Share
|